SHL TELEMEDICINE LTD (SHMLF) Financials
Newest figures come from the 10-K for FY2024, filed May 15, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SHMLF SEC filings page.
SHL TELEMEDICINE LTD (SHMLF) reported $56.8M in revenue for fiscal year 2024, down 0.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The business is defined by a widening earnings-to-cash gap alongside a shrinking balance-sheet cushion, not by sales growth.
In FY2024, net loss was$27.8M while operating cash flow was-$372K , so reported earnings were far more negative than near-term cash generation. Depreciation and amortization of$7.5M explains part of that gap, but the remaining difference means earnings are not a direct proxy for cash consumption.
Revenue was
Assets, equity, and goodwill all contracted in FY2024, indicating a substantial balance-sheet reset rather than only a one-year income-statement fluctuation. The current ratio fell from 2.3x to 1.0x, leaving little short-term cushion, while debt-to-equity remained low.
Financial Health Signals
SHL TELEMEDICINE LTD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
SHL TELEMEDICINE LTD passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
SHL TELEMEDICINE LTD reported a net loss of $27.8M while operations used $372K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2024.
Cash & Balance Sheet
SHL TELEMEDICINE LTD held $7.7M in cash against $3.6M in long-term debt as of Q4 2024.
Not reported for Q4 2024.
Not reported for Q4 2024.
Margins & Returns
None of these metrics is reported for Q4 2024.
Capital Allocation
None of these metrics is reported for Q4 2024.
SHMLF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
SHMLF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2410-K | Q2'2410-Q | Q4'2310-K | Q2'2310-Q | Q4'2210-K | Q2'2210-Q | Q4'2110-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $80.8M-28.6% | $102.8M-14.2% | $113.0M+2.0% | $119.8M+4.8% | $110.8M-14.5% | $114.3M | $129.6M |
| Current Assets | $27.5M-31.4% | $33.1M-25.4% | $40.1M+24.1% | $44.4M+15.0% | $32.3M-29.6% | $38.6M | $45.9M |
| Cash & Equivalents | $7.7M+14.7% | $10.9M+4.4% | $6.7M+49.3% | $10.4M-36.4% | $4.5M-69.8% | $16.4M | $14.8M |
| Inventory | $1.2M-66.1% | $2.9M-27.4% | $3.5M-10.8% | $4.0M-19.4% | $3.9M-7.7% | $5.0M | $4.2M |
| Goodwill | $19.1M-42.0% | $31.8M-1.6% | $33.0M-2.3% | $32.3M-3.3% | $33.7M-10.0% | $33.4M | $37.5M |
| Total Liabilities | $41.5M+13.5% | $32.6M-19.0% | $36.6M-28.9% | $40.2M-31.5% | $51.5M-25.2% | $58.6M | $68.8M |
| Current Liabilities | $26.5M+52.2% | $15.2M-4.1% | $17.4M-2.2% | $15.9M-1.8% | $17.8M+2.7% | $16.2M | $17.4M |
| Non-Current Liabilities | $15.0M-21.8% | $17.3M-28.7% | $19.1M-43.1% | $24.3M-42.8% | $33.7M-34.6% | $42.5M | $51.5M |
| Long-Term Debt | $3.6M-25.4% | $4.6M-47.6% | $4.8M-48.4% | $8.8M-5.1% | $9.3M-16.9% | $9.3M | $11.2M |
| Total Equity | $39.2M-48.7% | $70.3M-11.8% | $76.5M+29.0% | $79.6M+43.0% | $59.3M-2.4% | $55.7M | $60.8M |
| Retained Earnings | -$108.2M-35.1% | -$84.1M-11.7% | -$80.1M-9.7% | -$75.3M-3.2% | -$73.1M-0.1% | -$73.0M | -$73.0M |
Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.
SHMLF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
SHMLF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Where SHL TELEMEDICINE LTD Ranks
Frequently Asked Questions
What is SHL TELEMEDICINE LTD's annual revenue?
SHL TELEMEDICINE LTD (SHMLF) reported $56.8M in total revenue for fiscal year 2024. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is SHL TELEMEDICINE LTD's revenue growing?
SHL TELEMEDICINE LTD (SHMLF) revenue declined by 0.5% year-over-year, from $57.1M to $56.8M in fiscal year 2024.
Is SHL TELEMEDICINE LTD profitable?
No, SHL TELEMEDICINE LTD (SHMLF) reported a net income of -$27.8M in fiscal year 2024, with a net profit margin of -48.9%.
How much debt does SHL TELEMEDICINE LTD have?
As of fiscal year 2024, SHL TELEMEDICINE LTD (SHMLF) had $7.7M in cash and equivalents against $3.6M in long-term debt.
What is SHL TELEMEDICINE LTD's net profit margin?
SHL TELEMEDICINE LTD (SHMLF) had a net profit margin of -48.9% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is SHL TELEMEDICINE LTD's return on equity (ROE)?
SHL TELEMEDICINE LTD (SHMLF) has a return on equity of -70.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is SHL TELEMEDICINE LTD's free cash flow?
SHL TELEMEDICINE LTD (SHMLF) recorded an outflow of $1.3M in free cash flow during fiscal year 2024. This represents a 52.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is SHL TELEMEDICINE LTD's operating cash flow?
SHL TELEMEDICINE LTD (SHMLF) recorded an outflow of $372K in operating cash flow during fiscal year 2024, representing cash used by core business activities.
What are SHL TELEMEDICINE LTD's total assets?
SHL TELEMEDICINE LTD (SHMLF) had $80.8M in total assets as of fiscal year 2024, including both current and long-term assets.
What are SHL TELEMEDICINE LTD's capital expenditures?
SHL TELEMEDICINE LTD (SHMLF) invested $950K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is SHL TELEMEDICINE LTD's current ratio?
SHL TELEMEDICINE LTD (SHMLF) had a current ratio of 1.04 as of fiscal year 2024, which is considered adequate.
What is SHL TELEMEDICINE LTD's debt-to-equity ratio?
SHL TELEMEDICINE LTD (SHMLF) had a debt-to-equity ratio of 0.09 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is SHL TELEMEDICINE LTD's return on assets (ROA)?
SHL TELEMEDICINE LTD (SHMLF) had a return on assets of -34.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is SHL TELEMEDICINE LTD's Piotroski F-Score?
SHL TELEMEDICINE LTD (SHMLF) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are SHL TELEMEDICINE LTD's earnings high quality?
SHL TELEMEDICINE LTD (SHMLF) reported a net loss of $27.8M while operations used $372K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.